This complexity further prolongs the development process by 1824 months versus single-agent programs and raises manufacturing expenses by an estimated 35-45% relative to manufacturing expenses of GLP-1 monotherapy, which can be a challenge in price-sensitive regions
J Hepatol 65:369376 Kato H, Nagai Y, Ohta A et al (2015) Effect of sitagliptin on intrahepatic lipid content and body fat in patients with type 2 diabetes
LIPOLAB, manufactured by Innoaesthetics Korea, contains phosphatidylcholine (PPC) and sodium deoxycholate as its primary active ingredients the same mechanism used in FDA-approved Kybella
If you need to fly, purchasing a larger supply (closer to the 90-day personal import limit) on fewer trips makes more financial sense
Roughly 80% of treatment-related indigestion resolves or significantly improves by week 4, even without medication changes
When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount
